Phase 2a randomized, double-blind, vehicle-controlled, intra-individual comparison trial assessing safety, toleration, pharmacokinetics and pilot efficacy of 4 weeks treatment with topical CP-690,550 in chronic plaque psoriasis
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2009
At a glance
- Drugs Tofacitinib (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 11 Oct 2009 New trial record.